{"mcpName":"station__algovigilance__microgram-fda-benefit-risk-framework","slug":"algovigilance__microgram-fda-benefit-risk-framework","label":"Microgram: fda-benefit-risk-framework","description":"FDA structured benefit-risk assessment framework: routes 5-dimension evaluation to approval recommendation per FDA Guidance 'Benefit-Risk Assessment for New Drug and Biological Products' (2023)","domainSlug":"algovigilance","pvRelevance":"pv-core","backend":"native","agentMetadata":{"idempotent":true,"read_only":true,"expected_latency_ms":null,"cost_tokens_estimate":null,"pipes_to":null},"inputSchema":{"type":"object","properties":{"unmet_medical_need":{"type":"string","description":"Level of unmet medical need: high, moderate, low"},"benefit_evidence":{"type":"string","description":"Strength of efficacy evidence: strong, moderate, weak"},"risk_severity":{"type":"string","description":"Severity of identified risks: severe, moderate, mild"},"risk_management":{"type":"string","description":"Adequacy of risk management: adequate, partial, inadequate"},"therapeutic_alternatives":{"type":"string","description":"Availability of alternatives: none, few, many"}},"required":["unmet_medical_need","benefit_evidence","risk_severity","risk_management"],"additionalProperties":false},"example":null,"taxonomy":{"rank":{"domain":"Substrata","kingdom":"Constructa","phylum":"Configa","class":"station-config","order":"algovigilance","family":"mcp-tool-config"},"characteristics":{"substrate":"config","domain":"pv","lifecycle":"continuous","stateful":false,"persistence":"none","authority":"read","compounding":"producer","io_input":"agent-request","io_output":"tool-response"}},"_links":{"html":"/tools/algovigilance__microgram-fda-benefit-risk-framework","markdown":"/tools/algovigilance__microgram-fda-benefit-risk-framework/raw.md","invoke":"/api/mcp","catalog":"/api/mcp"}}